Oncolytic Virotherapy for Hematological Malignancies
Hematological malignancies such as leukemias, lymphomas, multiple myeloma (MM), and the myelodysplastic syndromes (MDSs) primarily affect adults and are difficult to treat. For high-risk disease, hematopoietic stem cell transplant (HCT) can be used. However, in the setting of autologous HCT, relapse...
Saved in:
Main Authors: | Swarna Bais, Eric Bartee, Masmudur M. Rahman, Grant McFadden, Christopher R. Cogle |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Advances in Virology |
Online Access: | http://dx.doi.org/10.1155/2012/186512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Oncolytic virotherapy, volume II
by: Ahmed Majeed Al-Shammari, et al.
Published: (2025-01-01) -
The replicability of oncolytic virus: Defining conditions in tumor virotherapy
by: Jianjun Paul Tian
Published: (2011-05-01) -
Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis
by: Joseph Malinzi, et al.
Published: (2018-11-01) -
Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations
by: Alaa A. Abdelmageed, et al.
Published: (2024-12-01) -
Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
by: Pradyumna Agasthi, et al.
Published: (2018-01-01)